Are patients with NASH and cryptogenic cirrhosis less likely than those with hepatitis C to receive liver transplants?
Patients with NASH and CC and low MELD scores have slower disease progression than patients with HCV-associated cirrhosis and are less likely to receive OLT.
Our data suggest that the urinary ACE2 level is closely associated with T2DM and is an independent risk factor for microalbuminuria.